Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE2

Conditions

High Grade Astrocytic Tumor · Recurrent Glioblastoma, IDH-Wildtype · Recurrent Gliosarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Principal Investigator (Jian L. Campian, MD, PhD)

Study leads

Jian L. Campian, MD, PhD
Principal Investigator
Mayo Clinic in Rochester

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Glioblastoma, IDH-Wildtype · Progressive Astrocytoma, IDH-Mutant, Grade 4 · Progressive Glioblastoma

Abroad (travel likely)RecruitingPHASE2

Rochester, United States

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Recurrent High Grade Glioma · Anaplastic Astrocytoma · Anaplastic Oligodendroglioma

Abroad (travel likely)RecruitingPHASE1

Omaha, United States

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

Recurrent Astrocytoma, IDH-Mutant, Grade 4 · Recurrent Glioblastoma, IDH-Wildtype

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Glioblastoma (GBM) · High Grade Gliomas · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Columbus, United States · Edinburgh, United Kingdom